From the country’s strategy for tackling COVID-19 to U.S.-China tensions to government regulations, some key changes can be expected under the coming Biden administration. At the same time, however, a split Congress (which is widely anticipated) is likely to hamper major changes in other areas, including drug pricing reform and federal stimulus. So which stocks and ETFs stand to benefit from the coming changes/lack of change? For a whole bunch of them, CLICK HERE.
23 Stocks And ETFs That Stand To Benefit From A Biden Administration’s Changes (Or A Split Congress’ Lack Of Change)
Tags:Biden AdministrationCOVID-19Drug Pricing ReformETFsGovernment Regulationsinvestorsstock marketstocksU.S.-China Tensions